Skip to main content
SpringerLink
Log in

18F-FDG uptake of the right ventricle is an important predictor of histopathologic diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis

  • Original Article
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

The aim of this study was to determine whether right ventricle (RV) 18F-fluorodeoxyglucose (FDG) uptake can predict positive findings of endomyocardial biopsy (EMB) in patients with cardiac sarcoidosis (CS).

Methods

70 consecutive patients with clinically diagnosed CS who had undergone FDG PET were registered in the present study. Patients without EMB (n = 42) were excluded. Ultimately, 28 patients were studied. EMB samples were obtained from the RV septum. We evaluated the FDG uptake on six segments (RV, left ventricle anterior, septal, lateral, inferior, and apex).

Results

Positive EMB was found in six patients (21%). Patients were divided into two groups according to positive (n = 12 [43%]) or negative (n = 16 [57%]) RV FDG uptake. Patients with positive RV FDG uptake had a significantly higher frequency of positive EMB than those without (42% vs. 6%, P = 0.024). On the other hand, there was no EMB-predictive value for the FDG uptakes in the other five segments, the cardiac metabolic volume, total lesion glycolysis, left ventricular ejection fraction, or any electrocardiogram findings.

Conclusions

FDG uptake of the RV but no other heart segment was associated with positive EMB in CS patients. The presence of RV FDG uptake could improve the rate of positive EMB up to 42% in patients with CS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Abbreviations

CMV:

Cardiac metabolic volume

CS:

Cardiac sarcoidosis

EMB:

Endomyocardial biopsy

FDG:

18F-fluorodeoxyglucose

LV:

Left ventricle

LVEF:

Left ventricular ejection fraction

PET:

Positron emission tomography

RV:

Right ventricle

SUV:

Standardized uptake value

TLG:

Total lesion glycolysis

References

  1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65.

    Article  CAS  Google Scholar 

  2. Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014;63:329-36.

    Article  Google Scholar 

  3. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet 2014;383:1155-67.

    Article  Google Scholar 

  4. Chiu CZ, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005;95:143-6.

    Article  CAS  Google Scholar 

  5. Nagai T, Nagano N, Sugano Y, Asaumi Y, Aiba T, Kanzaki H, et al. Effect of Corticosteroid Therapy on Long-Term Clinical Outcome and Left Ventricular Function in Patients With Cardiac Sarcoidosis. Circ J 2015;79:1593-600.

    Article  CAS  Google Scholar 

  6. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305-23.

    Article  Google Scholar 

  7. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302.

    Article  CAS  Google Scholar 

  8. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538-43.

    Article  Google Scholar 

  9. Manabe O, Oyama-Manabe N, Ohira H, Tsutsui H, Tamaki N. Multimodality evaluation of cardiac sarcoidosis. J Nucl Cardiol 2012;19:621-4.

    Article  Google Scholar 

  10. Mc Ardle BA, Leung E, Ohira H, Cocker MS, deKemp RA, DaSilva J, et al. The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis. J Nucl Cardiol 2013;20:297-306.

    Article  CAS  Google Scholar 

  11. Manabe O, Yoshinaga K, Ohira H, Sato T, Tsujino I, Yamada A, et al. Right ventricular 18F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis. Ann Nucl Med 2014;28:656-63.

    Article  CAS  Google Scholar 

  12. Simonen P, Lehtonen J, Kandolin R, Schildt J, Marjasuo S, Miettinen H, et al. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis. Am J Cardiol 2015;116:1581-5.

    Article  Google Scholar 

  13. Terasaki F, Yoshinaga K. New guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol 2017;3:42-5.

    Article  Google Scholar 

  14. Schiller NB, Acquatella H, Ports TA, Drew D, Goerke J, Ringertz H, et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 1979;60:547-55.

    Article  CAS  Google Scholar 

  15. Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18F-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 2009;16:801-10.

    Article  Google Scholar 

  16. Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006;13:e121-51.

    Article  Google Scholar 

  17. Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol 2016;23:244-52.

    Article  Google Scholar 

  18. Hirata K, Kobayashi K, Wong KP, Manabe O, Surmak A, Tamaki N, et al. A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT. PLoS ONE 2014;9:e105682.

    Article  Google Scholar 

  19. Manabe O, Kroenke M, Aikawa T, Murayama A, Naya M, Masuda A et al. Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake. J Nucl Cardiol 2017.

  20. Ishiyama M, Soine LA, Vesselle HJ. Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis. EJNMMI Res 2017;7:67.

    Article  Google Scholar 

  21. Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 2009;104:571-7.

    Article  Google Scholar 

  22. Tuominen H, Haarala A, Tikkakoski A, Kahonen M, Nikus K, Sipila K. 18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes. J Nucl Cardiol 2018.

  23. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, et al. Cardiac sarcoidosis. Am Heart J 2009;157:9-21.

    Article  CAS  Google Scholar 

  24. Doughan AR, Williams BR. Cardiac sarcoidosis. Heart. 2006;92:282-8.

    Article  Google Scholar 

  25. Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivisto SM, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011;270:461-8.

    Article  CAS  Google Scholar 

  26. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology Eur Heart J. 2007;28:3076-93.

    Article  Google Scholar 

  27. Koiwa H, Tsujino I, Ohira H, Yoshinaga K, Otsuka N, Nishimura M. Images in cardiovascular medicine: imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: an autopsy case. Circulation 2010;122:535-6.

    Article  Google Scholar 

  28. Holzmann M, Nicko A, Kuhl U, Noutsias M, Poller W, Hoffmann W, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 2008;118:1722-8.

    Article  Google Scholar 

  29. Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 2010;122:900-9.

    Article  Google Scholar 

  30. Slawek S, Araszkiewicz A, Gaczkowska A, Koszarska J, Celinski D, Grygier M, et al. Endomyocardial biopsy via the femoral access - still safe and valuable diagnostic tool. BMC Cardiovasc Disord 2016;16:222.

    Article  Google Scholar 

  31. Nery PB, Keren A, Healey J, Leug E, Beanlands RS, Birnie DH. Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. Can J Cardiol 2013;29:e1-3.

    Google Scholar 

Download references

Acknowledgements

The authors are grateful to Dr Tomoko Mitsuhashi and Dr Ken Kuwahara for their support with the histologic evaluation. The authors are also grateful to Kota Ohno, PhD, for statistical support.

Disclosure

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan

    Kazunori Omote MD, Masanao Naya MD, PhD, Kazuhiro Koyanagawa MD, Tadao Aikawa MD, PhD, Toshiyuki Nagai MD, PhD, Kiwamu Kamiya MD, PhD, Yoshiya Kato MD, Hirokazu Komoriyama MD, Masato Kuzume MD & Toshihisa Anzai MD, PhD

  2. Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan

    Osamu Manabe MD, PhD

  3. Department of Radiology, Kyoto Prefectural University of Medicine, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan

    Nagara Tamaki MD, PhD

Authors
  1. Kazunori Omote MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masanao Naya MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuhiro Koyanagawa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tadao Aikawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Osamu Manabe MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toshiyuki Nagai MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kiwamu Kamiya MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshiya Kato MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hirokazu Komoriyama MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masato Kuzume MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nagara Tamaki MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Toshihisa Anzai MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masanao Naya MD, PhD.

Additional information

The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarizes the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.

Funding

None.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Omote, K., Naya, M., Koyanagawa, K. et al. 18F-FDG uptake of the right ventricle is an important predictor of histopathologic diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis. J. Nucl. Cardiol. 27, 2135–2143 (2020). https://doi.org/10.1007/s12350-018-01541-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-018-01541-7

Keywords

Search

Navigation